Correction: Milnacipran for Treatment of Fibromyalgia

Kyle JA Dugan BD Testerman KK . Milnacipran for treatment of fibromyalgia. Ann Pharmacother 2010;44:1422–9. DOI 10.1345/aph.1P218.

Gendreau RM Thorn MD Gendreau JF Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975–85.

Clauw DJ Mease P Palmer RH Gendreau RM Wang Y . Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988–2004 (correction, Clin Ther 2009;31:446). DOI 10.1016/j.clinthera.2008.11.009.

Mease PJ Clauw D Gendreau RM The efficacy and safety of milnacipran for the treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398–409 (correction, J Rheumatol 2009;36:661). DOI 10.3899/jrheum.080734.

Arnold LM Gendreau RM Palmer RH Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia. Arthritis Rheum 2010;62:2745–56. DOI 10.1002/art.27559.

Product information. Savella (milnacipran). New York, NY: Forest Pharmaceuticals, Inc., December 2009.